{"transactions":[{"id":1676043,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T23:39:02.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":361469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-24-001870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001870/doc4.xml","form_type":"4"}},{"id":1676042,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T23:39:02.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":10.93,"value":196740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":136748,"source":{"system":"sec-edgar","filing":"0001209191-24-001870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001870/doc4.xml","form_type":"4"}},{"id":1676041,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T23:39:02.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":2.22,"value":39960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":154748,"source":{"system":"sec-edgar","filing":"0001209191-24-001870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001870/doc4.xml","form_type":"4"}},{"id":1704327,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-20T00:22:46.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":379469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-23-059254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123059254/doc4.xml","form_type":"4"}},{"id":1704326,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:22:46.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":9.6,"value":172800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":136748,"source":{"system":"sec-edgar","filing":"0001209191-23-059254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123059254/doc4.xml","form_type":"4"}},{"id":1704325,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:22:46.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":2.22,"value":39960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":154748,"source":{"system":"sec-edgar","filing":"0001209191-23-059254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123059254/doc4.xml","form_type":"4"}},{"id":1736059,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-17T22:52:08.000Z","date":"2023-11-15","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":397469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-23-055843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055843/doc4.xml","form_type":"4"}},{"id":1736058,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-17T22:52:08.000Z","date":"2023-11-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":3603,"price":7.18,"value":25869.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":136748,"source":{"system":"sec-edgar","filing":"0001209191-23-055843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055843/doc4.xml","form_type":"4"}},{"id":1736057,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-17T22:52:08.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":6.51,"value":117180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":140351,"source":{"system":"sec-edgar","filing":"0001209191-23-055843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055843/doc4.xml","form_type":"4"}},{"id":1736056,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-17T22:52:08.000Z","date":"2023-11-15","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":2.22,"value":39960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":158351,"source":{"system":"sec-edgar","filing":"0001209191-23-055843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055843/doc4.xml","form_type":"4"}},{"id":1757928,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-18T21:34:38.000Z","date":"2023-10-16","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":415469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-23-053107","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123053107/doc4.xml","form_type":"4"}},{"id":1757927,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-18T21:34:38.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":6.3,"value":113400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":140351,"source":{"system":"sec-edgar","filing":"0001209191-23-053107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123053107/doc4.xml","form_type":"4"}},{"id":1757926,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-18T21:34:38.000Z","date":"2023-10-16","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":2.22,"value":39960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":158351,"source":{"system":"sec-edgar","filing":"0001209191-23-053107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123053107/doc4.xml","form_type":"4"}},{"id":1776998,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-19T21:50:48.000Z","date":"2023-09-15","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":433469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-23-050033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123050033/doc4.xml","form_type":"4"}},{"id":1776997,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-19T21:50:48.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":8.66,"value":155880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":140351,"source":{"system":"sec-edgar","filing":"0001209191-23-050033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123050033/doc4.xml","form_type":"4"}},{"id":1776996,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-19T21:50:48.000Z","date":"2023-09-15","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":2.22,"value":39960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":158351,"source":{"system":"sec-edgar","filing":"0001209191-23-050033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123050033/doc4.xml","form_type":"4"}},{"id":1802908,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T22:39:02.000Z","date":"2023-08-15","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":451469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-23-046424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046424/doc4.xml","form_type":"4"}},{"id":1802907,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-17T22:39:02.000Z","date":"2023-08-15","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":9.25,"value":166500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":140351,"source":{"system":"sec-edgar","filing":"0001209191-23-046424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046424/doc4.xml","form_type":"4"}},{"id":1802906,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-17T22:39:02.000Z","date":"2023-08-15","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":2.22,"value":39960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":158351,"source":{"system":"sec-edgar","filing":"0001209191-23-046424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046424/doc4.xml","form_type":"4"}},{"id":1802905,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-17T22:39:02.000Z","date":"2023-08-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":3603,"price":9.19,"value":33111.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":140351,"source":{"system":"sec-edgar","filing":"0001209191-23-046424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046424/doc4.xml","form_type":"4"}},{"id":1822047,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-27T22:31:10.000Z","date":"2023-07-26","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":469469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-043581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043581/doc4.xml","form_type":"4"}},{"id":1822046,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-27T22:31:10.000Z","date":"2023-07-25","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":489469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-043581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043581/doc4.xml","form_type":"4"}},{"id":1822045,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-27T22:31:10.000Z","date":"2023-07-26","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":14.41,"value":288200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":143954,"source":{"system":"sec-edgar","filing":"0001209191-23-043581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043581/doc4.xml","form_type":"4"}},{"id":1822044,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-27T22:31:10.000Z","date":"2023-07-26","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":2.22,"value":44400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":163954,"source":{"system":"sec-edgar","filing":"0001209191-23-043581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043581/doc4.xml","form_type":"4"}},{"id":1822043,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-27T22:31:10.000Z","date":"2023-07-25","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":14.3,"value":286000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":143954,"source":{"system":"sec-edgar","filing":"0001209191-23-043581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043581/doc4.xml","form_type":"4"}},{"id":1822042,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-27T22:31:10.000Z","date":"2023-07-25","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":2.22,"value":44400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":163954,"source":{"system":"sec-edgar","filing":"0001209191-23-043581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043581/doc4.xml","form_type":"4"}},{"id":1826635,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-19T23:01:52.000Z","date":"2023-07-18","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":509469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-042794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042794/doc4.xml","form_type":"4"}},{"id":1826634,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-19T23:01:52.000Z","date":"2023-07-17","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":539469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-042794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042794/doc4.xml","form_type":"4"}},{"id":1826633,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-19T23:01:52.000Z","date":"2023-07-18","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":13.74,"value":412200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":143954,"source":{"system":"sec-edgar","filing":"0001209191-23-042794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042794/doc4.xml","form_type":"4"}},{"id":1826632,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-19T23:01:52.000Z","date":"2023-07-18","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":2.22,"value":66600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":173954,"source":{"system":"sec-edgar","filing":"0001209191-23-042794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042794/doc4.xml","form_type":"4"}},{"id":1826631,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-19T23:01:52.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":11.72,"value":351600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":143954,"source":{"system":"sec-edgar","filing":"0001209191-23-042794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042794/doc4.xml","form_type":"4"}},{"id":1826630,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-19T23:01:52.000Z","date":"2023-07-17","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":2.22,"value":66600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":173954,"source":{"system":"sec-edgar","filing":"0001209191-23-042794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042794/doc4.xml","form_type":"4"}},{"id":1848812,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T22:56:44.000Z","date":"2023-06-16","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":569469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-038616","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123038616/doc4.xml","form_type":"4"}},{"id":1848811,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T22:56:44.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":599469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-038616","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123038616/doc4.xml","form_type":"4"}},{"id":1848810,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-20T22:56:44.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":9.41,"value":282300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023"}],"balance_after":143954,"source":{"system":"sec-edgar","filing":"0001209191-23-038616","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123038616/doc4.xml","form_type":"4"}},{"id":1848809,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-20T22:56:44.000Z","date":"2023-06-16","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":2.22,"value":66600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023"}],"balance_after":173954,"source":{"system":"sec-edgar","filing":"0001209191-23-038616","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123038616/doc4.xml","form_type":"4"}},{"id":1848808,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-20T22:56:44.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":9.67,"value":290100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023"}],"balance_after":143954,"source":{"system":"sec-edgar","filing":"0001209191-23-038616","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123038616/doc4.xml","form_type":"4"}},{"id":1848807,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-20T22:56:44.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":2.22,"value":66600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023"}],"balance_after":173954,"source":{"system":"sec-edgar","filing":"0001209191-23-038616","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123038616/doc4.xml","form_type":"4"}},{"id":1866112,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-05T22:29:44.000Z","date":"2023-06-02","kind":"sale","planned":true,"acquired":false,"shares":17865,"price":8.93,"value":159534.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."}],"balance_after":143954,"source":{"system":"sec-edgar","filing":"0001209191-23-034601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123034601/doc4.xml","form_type":"4"}},{"id":1866111,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-05T22:29:44.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":8.58,"value":214500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,717 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 22, 2023."}],"balance_after":161819,"source":{"system":"sec-edgar","filing":"0001209191-23-034601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123034601/doc4.xml","form_type":"4"}},{"id":1888373,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-17T22:20:45.000Z","date":"2023-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2230,"price":5.6,"value":12488.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":185102,"source":{"system":"sec-edgar","filing":"0001209191-23-030380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123030380/doc4.xml","form_type":"4"}},{"id":2006488,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T22:13:03.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":7486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":629469,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":7486},"source":{"system":"sec-edgar","filing":"0001209191-23-010774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123010774/doc4.xml","form_type":"4"}},{"id":2006487,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T22:13:03.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":1768,"price":8.42,"value":14886.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":187332,"source":{"system":"sec-edgar","filing":"0001209191-23-010774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123010774/doc4.xml","form_type":"4"}},{"id":2006486,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T22:13:03.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":746,"price":8.44,"value":6296.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":189100,"source":{"system":"sec-edgar","filing":"0001209191-23-010774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123010774/doc4.xml","form_type":"4"}},{"id":2006485,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T22:13:03.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":7486,"price":8.33,"value":62358.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":189846,"source":{"system":"sec-edgar","filing":"0001209191-23-010774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123010774/doc4.xml","form_type":"4"}},{"id":2006484,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T22:13:03.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":7486,"price":2.22,"value":16618.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":197332,"source":{"system":"sec-edgar","filing":"0001209191-23-010774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123010774/doc4.xml","form_type":"4"}},{"id":2032095,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:12:32.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":212507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":212507,"derivative":{"exercise_price":8.55,"expiration_date":"2033-02-01","underlying":"Class A Common Stock","underlying_shares":212507},"source":{"system":"sec-edgar","filing":"0001209191-23-007045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123007045/doc4.xml","form_type":"4"}},{"id":2032094,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:12:32.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":2994,"price":8.55,"value":25598.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":189846,"source":{"system":"sec-edgar","filing":"0001209191-23-007045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123007045/doc4.xml","form_type":"4"}},{"id":2032093,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:12:32.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This RSU vested immediately upon the grant date."}],"balance_after":192840,"source":{"system":"sec-edgar","filing":"0001209191-23-007045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123007045/doc4.xml","form_type":"4"}},{"id":2032092,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:12:32.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":106253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2023 and every three months thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,590 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022."}],"balance_after":182003,"source":{"system":"sec-edgar","filing":"0001209191-23-007045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123007045/doc4.xml","form_type":"4"}},{"id":2050432,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T22:01:51.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":636955,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-23-004043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123004043/doc4.xml","form_type":"4"}},{"id":2050431,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-01-19T22:01:51.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":10000,"price":9.1561,"value":91561.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $8.92 to $9.33 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":73160,"source":{"system":"sec-edgar","filing":"0001209191-23-004043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123004043/doc4.xml","form_type":"4"}},{"id":2050430,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-01-19T22:01:51.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":5000,"price":2.22,"value":11100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":83160,"source":{"system":"sec-edgar","filing":"0001209191-23-004043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123004043/doc4.xml","form_type":"4"}},{"id":2081127,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-19T22:32:17.000Z","date":"2022-12-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":641955,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-061999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122061999/doc4.xml","form_type":"4"}},{"id":2081126,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-19T22:32:17.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":10000,"price":8.8525,"value":88525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $8.54 to $9.14 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":78160,"source":{"system":"sec-edgar","filing":"0001209191-22-061999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122061999/doc4.xml","form_type":"4"}},{"id":2081125,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-19T22:32:17.000Z","date":"2022-12-15","kind":"exercise","acquired":true,"shares":5000,"price":2.22,"value":11100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":88160,"source":{"system":"sec-edgar","filing":"0001209191-22-061999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122061999/doc4.xml","form_type":"4"}},{"id":2111533,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-17T23:47:43.000Z","date":"2022-11-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":646955,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-20","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-057708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057708/doc4.xml","form_type":"4"}},{"id":2111532,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-17T23:47:43.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":4941,"price":11.9153,"value":58873.4973,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $11.34 to $12.32 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":83160,"source":{"system":"sec-edgar","filing":"0001209191-22-057708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057708/doc4.xml","form_type":"4"}},{"id":2111531,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-17T23:47:43.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":5059,"price":12.7,"value":64249.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":88101,"source":{"system":"sec-edgar","filing":"0001209191-22-057708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057708/doc4.xml","form_type":"4"}},{"id":2111530,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-17T23:47:43.000Z","date":"2022-11-15","kind":"exercise","acquired":true,"shares":5000,"price":2.22,"value":11100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":93160,"source":{"system":"sec-edgar","filing":"0001209191-22-057708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057708/doc4.xml","form_type":"4"}},{"id":2111529,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-17T23:47:43.000Z","date":"2022-11-15","kind":"tax_withholding","acquired":false,"shares":613,"price":11.86,"value":7270.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":88160,"source":{"system":"sec-edgar","filing":"0001209191-22-057708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057708/doc4.xml","form_type":"4"}},{"id":2135326,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-18T21:08:05.000Z","date":"2022-10-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":651955,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-20","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-053981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122053981/doc4.xml","form_type":"4"}},{"id":2135325,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-18T21:08:05.000Z","date":"2022-10-14","kind":"sale","acquired":false,"shares":5000,"price":10.6259,"value":53129.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.44 to $11.36 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":88773,"source":{"system":"sec-edgar","filing":"0001209191-22-053981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122053981/doc4.xml","form_type":"4"}},{"id":2135324,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-18T21:08:05.000Z","date":"2022-10-14","kind":"sale","acquired":false,"shares":5000,"price":11.21,"value":56050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":93773,"source":{"system":"sec-edgar","filing":"0001209191-22-053981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122053981/doc4.xml","form_type":"4"}},{"id":2135323,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-18T21:08:05.000Z","date":"2022-10-14","kind":"exercise","acquired":true,"shares":5000,"price":2.22,"value":11100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":98773,"source":{"system":"sec-edgar","filing":"0001209191-22-053981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122053981/doc4.xml","form_type":"4"}},{"id":2156939,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-16T22:58:53.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":656955,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-20","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-050400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122050400/doc4.xml","form_type":"4"}},{"id":2156938,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:58:53.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":400,"price":13.9725,"value":5589.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.93 to $14.07 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":93773,"source":{"system":"sec-edgar","filing":"0001209191-22-050400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122050400/doc4.xml","form_type":"4"}},{"id":2156937,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:58:53.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":9600,"price":13.3381,"value":128045.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.89 to $13.82 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":94173,"source":{"system":"sec-edgar","filing":"0001209191-22-050400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122050400/doc4.xml","form_type":"4"}},{"id":2156936,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:58:53.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":5000,"price":2.22,"value":11100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":103773,"source":{"system":"sec-edgar","filing":"0001209191-22-050400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122050400/doc4.xml","form_type":"4"}},{"id":2180662,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-17T22:35:33.000Z","date":"2022-08-16","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.  704,955 shares were originally subject to this stock option upon the grant date."}],"balance_after":661955,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-20","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-046464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122046464/doc4.xml","form_type":"4"}},{"id":2180661,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-17T22:35:33.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":30000,"price":12.6148,"value":378444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.06 to $12.96 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":98773,"source":{"system":"sec-edgar","filing":"0001209191-22-046464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122046464/doc4.xml","form_type":"4"}},{"id":2180660,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-17T22:35:33.000Z","date":"2022-08-16","kind":"exercise","acquired":true,"shares":25000,"price":2.22,"value":55500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person"}],"balance_after":128773,"source":{"system":"sec-edgar","filing":"0001209191-22-046464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122046464/doc4.xml","form_type":"4"}},{"id":2180659,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-17T22:35:33.000Z","date":"2022-08-15","kind":"tax_withholding","acquired":false,"shares":613,"price":12.96,"value":7944.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":103773,"source":{"system":"sec-edgar","filing":"0001209191-22-046464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122046464/doc4.xml","form_type":"4"}},{"id":2265201,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-18T23:20:43.000Z","date":"2022-05-16","kind":"tax_withholding","acquired":false,"shares":870,"price":5.67,"value":4932.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":104386,"source":{"system":"sec-edgar","filing":"0001209191-22-030257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122030257/doc4.xml","form_type":"4"}},{"id":2407882,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-09T02:11:26.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":5436,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5436,"derivative":{"exercise_price":11.4,"exercise_date":"2022-02-04","expiration_date":"2032-02-04","underlying":"Class A Common Stock","underlying_shares":5436},"source":{"system":"sec-edgar","filing":"0001209191-22-007918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007918/doc4.xml","form_type":"4"}},{"id":2407881,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-09T02:11:26.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":80450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":80450,"derivative":{"exercise_price":11.4,"expiration_date":"2032-02-04","underlying":"Class A Common Stock","underlying_shares":80450},"source":{"system":"sec-edgar","filing":"0001209191-22-007918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007918/doc4.xml","form_type":"4"}},{"id":2407880,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-09T02:11:26.000Z","date":"2022-02-04","kind":"tax_withholding","acquired":false,"shares":1114,"price":11.4,"value":12699.6,"ownership":{"direct":true},"balance_after":105256,"source":{"system":"sec-edgar","filing":"0001209191-22-007918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007918/doc4.xml","form_type":"4"}},{"id":2407879,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-09T02:11:26.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":2718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This RSU vested immediately upon the grant date."}],"balance_after":106370,"source":{"system":"sec-edgar","filing":"0001209191-22-007918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007918/doc4.xml","form_type":"4"}},{"id":2407878,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-09T02:11:26.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":40225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 382 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021."}],"balance_after":103652,"source":{"system":"sec-edgar","filing":"0001209191-22-007918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007918/doc4.xml","form_type":"4"}},{"id":2680429,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T20:00:40.000Z","date":"2021-06-02","kind":"exercise","acquired":false,"shares":45045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."}],"balance_after":686955,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-20","underlying":"Class A Common Stock","underlying_shares":45045},"source":{"system":"sec-edgar","filing":"0001209191-21-038174","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121038174/doc4.xml","form_type":"4"}},{"id":2680428,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-04T20:00:40.000Z","date":"2021-06-02","kind":"exercise","acquired":true,"shares":45045,"price":2.22,"value":99999.9,"ownership":{"direct":true},"balance_after":63045,"source":{"system":"sec-edgar","filing":"0001209191-21-038174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121038174/doc4.xml","form_type":"4"}},{"id":2741602,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-23T00:12:56.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":732000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO."}],"balance_after":732000,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-20","underlying":"Class A Common Stock","underlying_shares":732000},"source":{"system":"sec-edgar","filing":"0001209191-21-028049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028049/doc4.xml","form_type":"4"}},{"id":2741601,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-23T00:12:56.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":732000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO."}],"balance_after":0,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-30","underlying":"Common Stock","underlying_shares":732000},"source":{"system":"sec-edgar","filing":"0001209191-21-028049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028049/doc4.xml","form_type":"4"}},{"id":2741600,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-23T00:12:56.000Z","date":"2021-04-20","kind":"other","acquired":true,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001209191-21-028049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028049/doc4.xml","form_type":"4"}},{"id":2741599,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":95074,"kind":"person","name":"Virani Shafique","position":1,"cik":"0001856081","reported_name":"Virani Shafique","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. Dev. Officer"}}],"security":"Common Stock","published_at":"2021-04-23T00:12:56.000Z","date":"2021-04-20","kind":"other","acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-028049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028049/doc4.xml","form_type":"4"}}]}